Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02641093
Title Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Trisha Wise-Draper
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Louisville - James Graham Brown Cancer Center Louisville Kentucky 40202 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
University of Cincinnati Medical Center Cincinnati Ohio 45219 United States Details
Ohio State University Columbus Ohio 43210 United States Details
Medical University of South Carolina Charleston South Carolina 29425 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field